Sectoral / Thematic📊 NIFTY 500 TRI(SEBI default)
ITI Pharma and Healthcare Fund · Direct · Growth
NAV
₹20.4719
as of 16 Nov 2026
Expense Ratio
0.86%
Viewing Direct · Growth
Risk-o-meter: not yet available here. See the latest risk-o-meter in the fund house's official disclosure.
Lumpsum returns (CAGR)
- 1Y
- +16.15%
- 3Y
- +19.72%
- 5Y
- +15.42%
- Since Inception
- +15.34%
SIP returns (XIRR)
- 1Y
- +26.88%
- 3Y
- +15.04%
- 5Y
- +18.36%
- Since Inception
- +18.36%
Performance Comparison
Thinking about ITI Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseITI Mutual Fund
CategorySectoral / Thematic
BenchmarkNIFTY 500 TRI
Launch Date08 Nov 2021
AMFI Code149268
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹500
Exit Load1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units Nil if redeemed or switched out after completion of 12 months from the date of allotment of units
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
What this fund does
ITI Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ITI Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by ITI Mutual Fund. The fund has been operational for over 5 years. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 0.86%.